Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: An evaluation from the food and drug administration adverse event reporting system and review of the literature;Colitis isquémica con interferonas tipo I usadas en el tratamiento de hepatitis c y esclerosis múltiple: Una evaluación del sistema de reporte de eventos adversos de la administración de drogas y alimentos y revisión de laliteratura

Annals of Pharmacotherapy

Volumn 47, Issue 4, 2013, Pages 537-542

  Salk, Allison ^a,b   Stobaugh, Derrick J ^b   Deepak, Parakkal ^b   Ehrenpreis, Eli D ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c Highland Park Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ARTICLE; COMORBIDITY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HEPATITIS C; HUMAN; INFORMATION SCIENCE; ISCHEMIC COLITIS; MEDICAL LITERATURE; MEDLINE; MULTIPLE SCLEROSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NARANJO PROBABILITY SCALE; PRIORITY JOURNAL;

EID: 84876253940     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R526     Document Type: Article

References (31)

1. Parmar S, Platanias LC. Interferons: mechanisms of action and clinical applications. Curr Opin Oncol 2003;15:431-9.
2. Sozzani S, Bosisio D, Scarsi M, Tincani A. Type I interferons in systemic autoimmunity. Autoimmunity 2010;43:196-203.
3. Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 2011;9:409-16.
4. Abramowicz M. Pegylated interferon (PEG-intron) for chronic hepatitis C. Med Lett Drugs Ther 2001;43:54.
5. Zablocki E. Drug class overview: Chronic hepatitis can be hidden, lifelong infection. Manag Healthc Exec 2005;15:34-6.
6. Ahn J, Flamm S. Peginterferon-2b and ribavirin. Expert Rev Anti Infect Ther 2004;2:17-25.
7. Edwards L. The interferons. Dermatol Clin 2001;19:139-46.
8. Brandt L, Boley S. AGA technical review on intestinal ischemia. Gastroenterology 2000;118:954-68.
9. Sherid M, Ehrenpreis E. Types of colitis based on histology. Dis Mon 2011;57:457-89.
10. Chang L, Tong K, Ameen V. Ischemic colitis and complications of constipation association with the use of alosentron under a risk management plan: clinical characteristics, outcomes, and incidences. Am J Gastroenterol 2010;105:866-75.
11. Rasmussen D, Segars L. Case of ischemic colitis in a young adolescent associated with triphasic hormonal contraceptive therapy: a case report and review of the literature. W VA Med J 2011;107:22.
12. Westgeest H, Akol H, Schreuder T. Pure naratriptan-induced ischemic colitis: a case report. Turk J Gastroenterol 2010;21:42-4.
13. Dowd J, Bailey D, Moussa K, Nair S, Doyle R, Culpepper-Morgan J. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol 1999;94:2430-4.
14. Kawaguchi T, Ide T, Itou M, et al. Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review. J Viral Hepatitis 2012;19:e220-4.
15. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-91.
16. Tada H, Saitoh S, Nakagawa Y, et al. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C. J Gastroenterol 1996;31:582-4.
17. Sparano JA, Dutcher JP, Kaleya R, et al. Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer 1991;68: 1538-44.
18. Naranjo C, Busto U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
19. Horigome H, Takezono Y, Fujino N, Uchida A, Murasaki G. A case of ischemic colitis associated with interferon treatment. Nippon Shokakibyo Gakkai Zasshi 1996;93:181-4.
20. Fukushima Y, Funahashi H, Aoyagi Y, Satou T, Tubo K, Ozawa T. Ischemic colitis during interferon treatment for chronic hepatitis C. Prog Dig Endosc 2004;64:120-1.
21. Leung Y, Urbanski SJ, Schindel L, Myers RP. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Can J Gastroenterol 2006;20:661-3.
22. Iwamatsu H, Tsunajima K, Saitoh R, et al. A case of ischemic colitis occurring in pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C. Endosc Forum Dig Dis 2008;24:112-6.
23. Punnam SR, Pothula VR, Gourineni N, Punnam A, Ranganathan V. Interferon-ribavirin-associated ischemic colitis. J Clin Gastroenterol 2008;42:323-5.
24. Brandt LJ, Feuerstadt P. Intestinal ischemia. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease. Philadelphia: Saunders, 2010:2038.
25. Marcus EL, Tur-Kaspa R. Chronic hepatitis C virus infection in older adults. Clin Infect Dis 2005;41:1606-12.
26. Lau JY, Fang JW, Mizokami M, Gish RG, Wright TL. Hepatitis C. In: Runge MS, Patterson C, eds. Principles of molecular medicine. Totowa, NJ: Humana Press, 2006:542-53.
27. Ramagopalan SV, Sadovnick AD. Epidemiology of multiple sclerosis. Neurol Clin 2011;29:207-17.
28. Gurbuz AK, Gurbuz B, Salas L, Rosenshein NB, Donowitz M, Giardiello FM. Premarin-induced ischemic colitis. J Clin Gastroenterol 1994;19:108-11.
29. Chang L, Kahler KH, Sarawate C, Quimbo R, Kralstein J. Assessment of potential risk factors associated with ischaemic colitis. Neurogastroenterol Motil 2008;20:36-42.
30. Tursi A. Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C. Inflamm Bowel Dis 2007;13:1189-90.
31. Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28:109-18.